Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mercuri

Showing results (181-190 of 259) with videos related to

Pageof 26
Sort By:
La Chirurgia Degli Organi Di Movimento|October 1, 1985
[Neoadjuvant treatment of osteosarcoma and malignant fibrous histiocytoma of the bones of the extremities: preliminary results in 76 cases treated preoperatively with a methotrexate and cisplatin combination]G Bacci, M Mercuri, G Pignatti, et al.
Journal of Chemotherapy (Florence, Italy)|August 1, 1993
No advantages in the addition of ifosfamide and VP-16 to the standard four-drug regimen in the maintenance phase of neoadjuvant chemotherapy of Ewing's sarcoma of bone: results of two sequential studiesG Bacci, P Picci, P Ruggieri, et al.
Acta Orthopaedica Scandinavica|August 14, 1998
Predictive factors for local recurrence in osteosarcoma: 540 patients with extremity tumors followed for minimum 2.5 years after neoadjuvant chemotherapyG Bacci, S Ferrari, M Mercuri, et al.
Tumori|June 10, 1998
Non conventional fractionation in radiotherapy of the musculo-skeletal sarcomasE Barbieri, G Frezza, O Martelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1992
The treatment of localized osteosarcoma of the extremities: the Italian experience. Studies of the National Research CouncilP Picci, G Bacci, P Ruggieri, et al.
Clinical Orthopaedics and Related Research|March 1, 1991
The management of malignant bone tumors in children and adolescentsM Mercuri, R Capanna, M Manfrini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1997
Long-term follow-up and post-relapse survival in patients with non-metastatic osteosarcoma of the extremity treated with neoadjuvant chemotherapyS Ferrari, G Bacci, P Picci, et al.
Cancer|March 20, 1998
Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase--results of two sequential studiesG Bacci, P Picci, S Ferrari, et al.
Italian Journal of Orthopaedics and Traumatology|March 1, 1988
Neoadjuvant chemotherapy in the treatment of osteosarcoma of the extremities: preliminary results in 131 cases treated preoperatively with methotrexate and cisdiamminoplatinumG Bacci, M Avella, R Capanna, et al.
Metabolism: Clinical and Experimental|September 14, 2001
Relationship between high-density lipoprotein paraoxonase gene M/L55 polymorphism and carotid atherosclerosis differs in smoking and nonsmoking menR Malin, A Loimaala, A Nenonen, et al.
Pageof 26

Showing results (181-190 of 259) with videos related to

Sort By:
Pageof 26
La Chirurgia Degli Organi Di Movimento|October 1, 1985
[Neoadjuvant treatment of osteosarcoma and malignant fibrous histiocytoma of the bones of the extremities: preliminary results in 76 cases treated preoperatively with a methotrexate and cisplatin combination]G Bacci, M Mercuri, G Pignatti, et al.
Journal of Chemotherapy (Florence, Italy)|August 1, 1993
No advantages in the addition of ifosfamide and VP-16 to the standard four-drug regimen in the maintenance phase of neoadjuvant chemotherapy of Ewing's sarcoma of bone: results of two sequential studiesG Bacci, P Picci, P Ruggieri, et al.
Acta Orthopaedica Scandinavica|August 14, 1998
Predictive factors for local recurrence in osteosarcoma: 540 patients with extremity tumors followed for minimum 2.5 years after neoadjuvant chemotherapyG Bacci, S Ferrari, M Mercuri, et al.
Tumori|June 10, 1998
Non conventional fractionation in radiotherapy of the musculo-skeletal sarcomasE Barbieri, G Frezza, O Martelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1992
The treatment of localized osteosarcoma of the extremities: the Italian experience. Studies of the National Research CouncilP Picci, G Bacci, P Ruggieri, et al.
Clinical Orthopaedics and Related Research|March 1, 1991
The management of malignant bone tumors in children and adolescentsM Mercuri, R Capanna, M Manfrini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1997
Long-term follow-up and post-relapse survival in patients with non-metastatic osteosarcoma of the extremity treated with neoadjuvant chemotherapyS Ferrari, G Bacci, P Picci, et al.
Cancer|March 20, 1998
Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase--results of two sequential studiesG Bacci, P Picci, S Ferrari, et al.
Italian Journal of Orthopaedics and Traumatology|March 1, 1988
Neoadjuvant chemotherapy in the treatment of osteosarcoma of the extremities: preliminary results in 131 cases treated preoperatively with methotrexate and cisdiamminoplatinumG Bacci, M Avella, R Capanna, et al.
Metabolism: Clinical and Experimental|September 14, 2001
Relationship between high-density lipoprotein paraoxonase gene M/L55 polymorphism and carotid atherosclerosis differs in smoking and nonsmoking menR Malin, A Loimaala, A Nenonen, et al.
Pageof 26